AGCO Corp
AGCO
109.15
-7.04
-6.06%
AGCO Corp
US · AGCO
#1668 by market cap
Listed 1970
109.15
-7.04
-6.06%
Live - 5344 symbols - heartbeat 67s ago
· 2026-10-08 07:01
Pre-market
108.60
-0.50%
After-hours
109.15
0.00%
- Market cap
- 7.64B
- P/E (TTM)i
- 15.10
- P/Bi
- 1.87
- EPSi
- 9.75
- Div yieldi
- 1.07%
- 52W posi
- 25%
Reader sentiment
Are you bullish or bearish on AGCO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.52, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -13.55% YoY
Margins
- Gross margin
- 25.46%
- Operating margin
- 6.93%
- Net margin
- 7.21%
Key ratios & quality
- Enterprise valuei
- 9.22B
- Altman Z-Scorei
- 2.52
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.35B | 9.04B | 9.15B | 11.14B | 12.65B | 14.41B | 11.66B | 10.08B |
| Gross profit | 2.00B | 1.98B | 2.06B | 2.57B | 3.00B | 3.78B | 2.90B | 2.57B |
| Selling & admin expenses | 1.07B | 1.04B | 1.00B | 1.09B | 1.19B | 1.45B | 1.40B | 1.31B |
| Research & development | 355.20M | 343.40M | 342.60M | 405.80M | 444.20M | 548.80M | 493.00M | 487.70M |
| Operating profit | 507.40M | 539.50M | 653.90M | 1.02B | 1.31B | 1.72B | 927.40M | 698.70M |
| Pretax profit | 360.30M | 261.10M | 562.00M | 944.30M | 1.11B | 1.33B | -433.60M | 602.00M |
| Tax | 110.90M | 180.80M | 187.70M | 108.40M | 296.60M | 230.40M | 98.40M | -77.40M |
| Net profit | 283.70M | 122.80M | 419.80M | 901.50M | 874.70M | 1.17B | -485.60M | 719.00M |
| Basic EPS | 4 | 2 | 6 | 12 | 12 | 16 | -6 | 10 |
| Diluted EPS | 3.58 | 1.63 | 5.65 | 11.85 | 11.87 | 15.63 | -5.69 | 9.75 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.05B | 2.64B | 2.48B | 2.92B | 2.34B | 2.61B |
| Gross profit | 520.60M | 658.60M | 646.50M | 741.10M | 581.40M | 645.90M |
| Selling & admin expenses | 325.80M | 326.40M | 340.80M | 316.30M | 339.10M | 335.70M |
| Research & development | 116.00M | 117.80M | 123.00M | 130.90M | 132.60M | 141.20M |
| Operating profit | 63.50M | 198.70M | 159.70M | 276.80M | 92.80M | 151.90M |
| Pretax profit | -1.40M | 97.30M | 344.50M | 161.60M | 39.00M | 108.20M |
| Tax | 2.00M | -205.50M | 48.80M | 77.30M | 4.60M | 40.40M |
| Net profit | 8.70M | 314.40M | 302.70M | 93.20M | 52.40M | 74.80M |
| Basic EPS | 0 | 4 | 4 | 1 | 1 | 1 |
| Diluted EPS | 0.14 | 4.22 | 4.09 | 1.30 | 0.76 | 1.08 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.54B | 3.73B | 4.37B | 5.01B | 5.74B | 6.34B | 5.14B | 5.20B |
| Cash & ST investments | 326.10M | 429.60M | 1.11B | 882.20M | 787.50M | 595.00M | 612.00M | 861.10M |
| Inventory | 1.91B | 2.08B | 1.97B | 2.59B | 3.19B | 3.44B | 2.73B | 2.71B |
| Total assets | 7.63B | 7.76B | 8.50B | 9.18B | 10.10B | 11.42B | 11.19B | 11.93B |
| Total current liabilities | 2.77B | 2.88B | 3.36B | 3.45B | 4.09B | 4.34B | 3.83B | 3.73B |
| Short-term debt | 210.60M | 153.40M | 359.70M | 92.90M | 196.00M | 15.00M | 415.20M | 117.70M |
| Long-term debt | 1.28B | 1.19B | 1.26B | 1.41B | 1.26B | 1.38B | 2.23B | 2.32B |
| Total liabilities | 4,632,900,000.00 | 4,852,700,000.00 | 5,486,200,000.00 | 5,738,300,000.00 | 6,221,100,000.00 | 6,764,400,000.00 | 7,147,700,000.00 | 7,355,100,000.00 |
| Total equity | 2.99B | 2.91B | 3.02B | 3.44B | 3.88B | 4.66B | 4.04B | 4.57B |
| Retained earnings | 4.48B | 4.44B | 4.76B | 5.18B | 5.65B | 6.36B | 5.65B | 6.05B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 5.29B | 5.63B | 5.72B | 5.20B | 5.34B | 5.34B |
| Cash & ST investments | 562.60M | 783.90M | 884.10M | 861.10M | 514.90M | 573.40M |
| Inventory | 2.96B | 3.10B | 3.08B | 2.71B | 3.00B | 3.01B |
| Total assets | 11.48B | 12.31B | 12.47B | 11.93B | 12.04B | 11.88B |
| Total current liabilities | 3.46B | 3.80B | 3.63B | 3.73B | 4.13B | 4.04B |
| Short-term debt | 182.10M | 207.90M | 109.20M | 117.70M | 555.50M | 546.70M |
| Long-term debt | 2.76B | 2.76B | 2.73B | 2.32B | 2.02B | 2.18B |
| Total liabilities | 7,371,600,000.00 | 7,837,000,000.00 | 7,674,800,000.00 | 7,355,100,000.00 | 7,448,900,000.00 | 7,505,400,000.00 |
| Total equity | 4.11B | 4.47B | 4.79B | 4.57B | 4.59B | 4.37B |
| Retained earnings | 5.63B | 5.92B | 6.21B | 6.05B | 6.03B | 5.80B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 595.90M | 695.90M | 896.50M | 660.20M | 838.20M | 1.10B | 689.90M | 988.10M |
| Depreciation & amortization | 289.90M | 272.00M | 272.00M | 281.80M | 269.60M | 288.10M | 332.20M | 327.60M |
| Free cash flow | 392.60M | 422.50M | 626.60M | 390.40M | 449.90M | 585.00M | 296.60M | 740.20M |
| Dividends paid | -47.10M | -48.00M | -48.00M | -358.50M | -404.30M | -457.40M | -273.10M | -86.50M |
| Stock buybacks / issuance | -184.30M | -130.00M | -55.00M | -135.00M | 0 | -53.00M | -22.00M | -250.00M |
| Ending cash balance | 326.10M | 432.80M | 1.12B | 889.10M | 789.50M | 595.50M | 612.70M | 861.80M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -212.20M | 365.70M | 71.00M | 763.60M | -410.40M | 165.40M |
| Depreciation & amortization | 75.80M | 79.80M | 85.70M | 86.30M | 83.60M | 84.20M |
| Free cash flow | -260.40M | 323.50M | 2.10M | 675.00M | -455.00M | 108.20M |
| Dividends paid | -21.60M | -21.70M | -21.60M | -21.60M | -21.00M | -21.00M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 562.60M | 783.90M | 884.10M | 861.80M | 514.90M | 573.40M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 9.58 | 4.33 | 14.64 | 28.05 | 24.38 | 27.44 | -10.11 | 18.13 |
| ROA %i | 3.66 | 1.63 | 5.25 | 10.14 | 9.23 | 10.88 | -3.76 | 6.29 |
| ROIC %i | 7.07 | 3.20 | 9.64 | 18.51 | 17.12 | 20.17 | -5.60 | 11.62 |
| 5-year avg ROE %i | 8.24 | 6.90 | 8.13 | 12.60 | 16.19 | 19.77 | 16.88 | 17.57 |
| EBIT margin %i | 4.51 | 3.21 | 6.41 | 8.71 | 9.12 | 9.73 | -2.35 | 7.19 |
| FCF / sales %i | 4.20 | 4.67 | 6.85 | 3.51 | 3.56 | 4.06 | 2.54 | 7.34 |
| Current ratioi | 1.28 | 1.29 | 1.30 | 1.45 | 1.40 | 1.46 | 1.34 | 1.39 |
| Quick ratioi | 0.44 | 0.43 | 0.59 | 0.54 | 0.49 | 0.51 | 0.49 | 0.52 |
| Debt / assetsi | 19.48 | 19.25 | 20.49 | 17.64 | 15.70 | 13.37 | 24.81 | 21.49 |
| LT debt / equityi | 43.48 | 46.97 | 46.40 | 44.69 | 35.81 | 32.46 | 63.08 | 57.22 |
| Interest coveragei | 6.82 | 10.07 | 23.57 | 38.18 | 25.07 | 20.38 | -1.72 | 5.89 |
| Revenue CAGR (3Y) %i | 7.79 | 6.86 | 3.28 | 6.00 | 11.85 | 16.35 | 1.54 | -7.29 |
| Net income CAGR (3Y) %i | 2.33 | -7.87 | 31.83 | 46.46 | 92.25 | 39.98 | -- | -6.53 |
| FCF CAGR (3Y) %i | 7.87 | 35.86 | 18.80 | -0.19 | 2.12 | -2.26 | -8.75 | 18.05 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -13.60 | 2.42 | 8.69 | 18.13 | 19.02 | 12.93 |
| ROA %i | -4.67 | 0.77 | 2.89 | 6.29 | 6.56 | 4.41 |
| ROIC %i | -5.83 | 2.88 | 6.14 | 11.62 | 12.15 | 8.76 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -4.45 | -0.57 | 2.38 | 7.19 | 7.35 | 7.46 |
| FCF / sales %i | 4.65 | 6.76 | 7.45 | 7.34 | 5.26 | 3.19 |
| Current ratioi | 1.53 | 1.48 | 1.58 | 1.39 | 1.29 | 1.32 |
| Quick ratioi | 0.52 | 0.52 | 0.58 | 0.52 | 0.43 | 0.45 |
| Debt / assetsi | 26.77 | 25.16 | 23.80 | 21.49 | 22.34 | 23.90 |
| LT debt / equityi | 75.91 | 69.32 | 63.64 | 57.22 | 49.68 | 56.17 |
| Interest coveragei | -2.73 | -0.35 | 1.65 | 5.89 | 6.37 | 6.49 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Tractors is the largest reported line at 63.95% of revenue, across 4 reported segments.
- Replacement parts follows at 19.78%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Tractors63.95%
Replacement parts19.78%
Combines, application equipment and other machinery16.27%
Quote time 2026-10-08 07:01:37 · For reference only, not investment advice and not tailored to your situation.